Application 202002
- Type
- ANDA
- Sponsor
- STRIDES PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IMIQUIMOD | IMIQUIMOD | CREAM;TOPICAL | 5% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202002-001 | IMIQUIMOD | IMIQUIMOD | 5% | CREAM / TOPICAL | 2014-06-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A202002-001 | IMIQUIMOD | 5% | CREAM / TOPICAL | 2014-06-24 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A202002-001 | IMIQUIMOD | 5% | CREAM / TOPICAL | 2014-06-24 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A202002-001 | IMIQUIMOD | 5% | CREAM / TOPICAL | 2014-06-24 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Imiquimod | IMIQUIMOD | Sun Pharmaceutical Industries, Inc. | 51913a5a-1cab-4b9e-b2c2-e0174062df73 | 2026-01-21 | Warnings, Adverse reactions | Imiquimod IMIQUIMOD |
| Imiquimod | IMIQUIMOD | Bryant Ranch Prepack | 9291e5cd-b83d-4b43-88f5-30cac6cef5ff | 2025-11-05 | Warnings, Adverse reactions | Imiquimod IMIQUIMOD |
| Imiquimod | IMIQUIMOD | Bryant Ranch Prepack | f8db59e2-8052-413b-9f9f-07cd9eea07ec | 2025-09-25 | Warnings, Adverse reactions | Imiquimod IMIQUIMOD |
| Imiquimod | IMIQUIMOD | Sun Pharmaceutical Industries, Inc. | 59af8153-4cf8-4f22-9000-f239798d52d1 | 2025-08-11 | Boxed warning, Warnings, Adverse reactions | Imiquimod IMIQUIMOD |
| Imiquimod | IMIQUIMOD | Bryant Ranch Prepack | 47d3045f-a145-4095-bb8a-c67ba1ff3bda | 2025-07-29 | Warnings, Adverse reactions | Imiquimod IMIQUIMOD |
| Imiquimod | IMIQUIMOD | Teva Pharmaceuticals USA, Inc. | 9f2cbefd-f295-47e2-8a9e-3e7c5812c963 | 2025-06-30 | Warnings, Adverse reactions | Imiquimod IMIQUIMOD |
| Imiquimod | IMIQUIMOD | Oceanside Pharmacueticals | d86eeb0e-70e0-4c72-aaa3-37daa1d8611e | 2025-06-03 | Warnings, Adverse reactions | Imiquimod IMIQUIMOD |
| Zyclara | IMIQUIMOD | Bausch Health US, LLC | 28cd9b5b-680b-480f-b33d-9c5b52bbf03d | 2025-05-23 | Warnings, Adverse reactions | IMIQUIMOD |
| Imiquimod | IMIQUIMOD | Glenmark Pharmaceuticals Inc., USA | 663e39a9-a29e-473f-89ec-4c7c6bc27b8a | 2025-01-23 | Warnings, Adverse reactions | Imiquimod IMIQUIMOD |
| IMIQUIMOD | IMIQUIMOD | DIRECT RX | a18a3f7e-7254-56c0-e053-2a95a90a7036 | 2025-01-17 | Warnings, Adverse reactions | IMIQUIMOD IMIQUIMOD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 64380-773 | imiquimod | imiquimod | Strides Shasun Limited | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 9939 | ORIG | 2014-06-26 |